Content is free to use but usage restrictions apply. Please visit our FAQ for conditions of use. If you click download/embed, you acknowledge that you have read and will respect the terms of use.
The German Covid-19 vaccine manufacturer BioNTech has a complex network of manufacturing capabilities in Europe and there is also the Pfizer network in the United States.
Even if the coronavirus has mutated, German vaccine manufacturer BioNTech still believes that it is highly likely it can be combatted effectively. Company boss Ugur Sahin is considering new production facilities for the vaccine so that orders can be delivered earlier.